无创产前检测与超声提示胎儿性别不一致的解读
本文综述了cfDNA与超声诊断胎儿性别的原理,指出性染色体评估可在妊娠10周起进行,胎儿性别不一致的患病率约为1/1500-2000妊娠。文章分析了表型-基因型性别不一致的可能原因,并为临床医生咨询和管理此类夫妇提供了系统方法。
要点
- cfDNA检测使性染色体评估提前至妊娠10周,性别不一致检出率增加。
- 表型-基因型性别不一致可能提示遗传、染色体或生化异常,需系统评估。
- 早期识别性别不一致可为部分需出生后紧急治疗的疾病争取时间。
核心结论
- 胎儿性别不一致的产前诊断是相对新的现象,cfDNA检测使其更常见,患病率约1/1500-2000妊娠。
- 早期识别表型-基因型性别不一致很重要,可能提示潜在遗传、染色体或生化异常,并允许时间关键的产后治疗。
研究设计与样本
- 本文为综述,旨在回顾cfDNA和超声诊断胎儿性别,识别表型-基因型不一致的可能原因,并提供临床咨询和管理的系统方法。
主要发现
- cfDNA检测可在妊娠10周起进行性染色体评估,使胎儿性别不一致更常在产前诊断。
- 胎儿性别不一致的患病率约为1/1500-2000妊娠。
临床怎么用
- 临床医生应系统评估cfDNA与超声提示的胎儿性别不一致,考虑潜在遗传、染色体或生化条件。
- 咨询和管理此类夫妇时需提供系统方法,并关注可能的时间关键性产后治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prenatal diagnosis of sex discordance is a relatively new phenomenon. Prior to cell-free DNA testing, the diagnosis of a disorder of sexual differentiation was serendipitous, either through identification of ambiguous genitalia at the midtrimester morphology ultrasound or discovery of genotype-phenotype discordance in cases where preimplantation genetic diagnosis or invasive prenatal testing had occurred. The widespread integration of cfDNA testing into modern antenatal screening has made sex chromosome assessment possible from 10 weeks of gestation, and discordant fetal sex is now more commonly diagnosed prenatally, with a prevalence of approximately 1 in 1500-2000 pregnancies. Early detection of phenotype-genotype sex discordance is important as it may indicate an underlying genetic, chromosomal or biochemical condition and it also allows for time-critical postnatal treatment. The aim of this article is to review cfDNA and ultrasound diagnosis of fetal sex, identify possible causes of phenotype-genotype discordance and provide a systematic approach for clinicians when counseling and managing couples in this circumstance.
引用
- Smet ME, Scott FP, McLennan AC, et al. Discordant fetal sex on NIPT and ultrasound. Prenat Diagn. 2020. PMID: 32125721. doi:10.1002/pd.5676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。